NCCN Guidelines for Patients® | Chronic Myelogenous Leukemia - page 19

19
NCCN Guidelines for Patients
®
: Chronic Myelogenous Leukemia
Version 1.2014
Par t 7
Par t 6
Par t 5
Par t 4
Par t 3
Par t 2
Par t 1
2.4 Tools
Questions about testing to ask your doctor
• What tests will I have? How often will I be tested?
• Where will the tests take place? Will I have to go to the hospital?
• How long will it take? Will I be awake?
• Will it hurt? Will I need anesthesia?
• What are the risks? What are the chances of infection or bleeding afterward?
• How do I prepare for testing? Should I not take aspirin? Should I not eat
beforehand?
• Should I bring a list of my medications? Should I bring someone with me?
• How long will it take for me to recover? Will I be given an antibiotic or other
drug afterward?
• If a biopsy is done, will I get a copy of the results?
• How often will I have bone marrow tests? Will you remove the sample of bone
marrow from the hip or from another bone?
• How soon will I know the test results and who will explain them to me?
• Who will talk with me about the next steps? When?
Definitions:
Baseline:
Starting point to
which future test results are
compared
BCR-ABL
gene:
Abnormal
set of instructions in cells,
formed when the
BCR
and
ABL
genes join (fuse)
BCR-ABL protein:
Abnormal protein that
causes too many white
blood cells to be made
DNA:
Molecules that
contain genes—coded
instructions in cells for
making and controlling cells
Lymphoid:
Referring to
a type of white blood cell
called a lymphocyte
Myeloid:
Referring to a
type of white blood cell
called a granulocyte
DNA =
Deoxyribonucleic
acid
Acronyms:
1...,9,10,11,12,13,14,15,16,17,18 20,21,22,23,24,25,26,27,28,29,...100
Powered by FlippingBook